You have 9 free searches left this month | for more free features.

Crohn's disease; adherence; medication concern; infliximab

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Medication Belief on Adherence to Infliximab in Crohn's Disease

Completed
  • Inflammatory Bowel Diseases
    • Zhejiang, China
      2ndAffiliated Hospital, School of Medicine, Zhejiang University,
    Mar 8, 2023

    IBD, Crohn Disease, Ulcerative Colitis Trial (Remote monitoring)

    Recruiting
    • Inflammatory Bowel Diseases
    • +2 more
    • Remote monitoring
    • Baltimore, Maryland
    • +4 more
    Jan 11, 2023

    IBD, Crohn Disease, Ulcerative Colitis Trial (Infliximab)

    Not yet recruiting
    • Inflammatory Bowel Diseases
    • +2 more
    • (no location specified)
    Oct 27, 2023

    Crohn Disease, Child, Only, Biologic; Inadequate Trial (Infliximab)

    Not yet recruiting
    • Crohn Disease
    • +2 more
    • (no location specified)
    Sep 20, 2022

    Sterile Corneal Melt Trial in Montreal (Topical Infliximab)

    Recruiting
    • Sterile Corneal Melt
    • Topical Infliximab
    • Montreal, Quebec, Canada
      Centre Hospitalier de l'Université de Montréal
    Dec 12, 2022

    Crohn Disease, Infliximab, Perianal Fistula Due to Crohn's Disease Trial (TDM-based infliximab intravenous therapy, Standard

    Not yet recruiting
    • Crohn Disease
    • +4 more
    • TDM-based infliximab intravenous therapy
    • Standard infliximab intravenous therapy
    • (no location specified)
    Sep 26, 2023

    IBD, IBD, Crohn Disease Trial in Cincinnati (SMART-IBD)

    Recruiting
    • Inflammatory Bowel Diseases
    • +3 more
    • SMART-IBD
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Sep 1, 2023

    Crohn Disease Trial in Beijing (Infliximab)

    Not yet recruiting
    • Crohn Disease
    • Beijing, China
      Beijing Children's Hospital, Capital Medical University
    Jun 13, 2023

    IBD Trial in Saint Louis (Infliximab)

    Active, not recruiting
    • Inflammatory Bowel Diseases
    • Saint Louis, Missouri
      Washington University School of Medicine
    Aug 31, 2022

    Crohn's Disease Trial in Seoul (Infliximab-Dyyb)

    Not yet recruiting
    • Crohn's Disease
    • Seoul, Korea, Republic of
      Asan Medical Center
    Oct 5, 2023

    IBD, Crohn Disease, Ulcerative Colitis Trial in Moscow (Telemedical intervention)

    Enrolling by invitation
    • Inflammatory Bowel Diseases
    • +2 more
    • Telemedical intervention
    • Moscow, Russian Federation
      Research and Practical Clinical Center for Diagnostics and Telem
    Aug 8, 2023

    Inflammatory Disease, Disease Crohn, Bowel Disease Trial in Amsterdam (Infliximab subcutaneous, Immunosuppressive Agents)

    Recruiting
    • Inflammatory Disease
    • +2 more
    • Infliximab subcutaneous
    • Immunosuppressive Agents
    • Amsterdam, North Holland, Netherlands
      Amsterdam UMC AMC
    Sep 27, 2023

    A 24-month Real Life PErsistence Efficacy and Safety Study in

    Recruiting
    • Inflammatory Bowel Diseases
    • Subcutaneous infliximab CT-P13 Remsima®SC
    • Grenoble, France
      Nicolas Mathieu
    Aug 2, 2022

    Crohn's Disease Trial (MR Enterography (MRE))

    Not yet recruiting
    • Crohn's Disease
    • MR Enterography (MRE)
    • (no location specified)
    Nov 13, 2023

    A Multicentered Prospective Cohort Study of Chinese IBD Patients

    Enrolling by invitation
    • Ulcerative Colitis
    • Crohn Disease
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 17, 2022

    Atherosclerosis Trial in Essen (Medication management app (mediteo m+, Mediteo GmbH, Heidelberg))

    Recruiting
    • Atherosclerosis
    • Medication management app (mediteo m+, Mediteo GmbH, Heidelberg)
    • Essen, Nordrhein-Westfalen, Germany
      University Hospital, Essen
    Mar 8, 2023

    Crohn Disease Trial in United States (RoadMAB, Infliximab)

    Not yet recruiting
    • Crohn Disease
    • Los Angeles, California
    • +9 more
    Dec 19, 2022

    Tuberculosis Trial in Mbarara (SMS texts + incentives + Wisepill device for medication monitoring, SMS texts only + Wisepill

    Recruiting
    • Tuberculosis
    • SMS texts + incentives + Wisepill device for medication monitoring
    • +2 more
    • Mbarara, Uganda
      Mbarara Regional Referral Hospital
    Dec 15, 2022

    Medicine Called Infliximab[Infliximab Biosimilar 3] in People

    Not yet recruiting
    • Arthritis, Rheumatoid
    • +3 more
      • (no location specified)
      Mar 31, 2023

      Chronic Kidney Disease Trial in Islamabad (Pharmacist counselling)

      Active, not recruiting
      • Chronic Kidney Disease
      • Pharmacist counselling
      • Islamabad, Pakistan
        Akbar Niazi Teaching Hospital
      Oct 12, 2023

      Infliximab in the Treatment of Chinese Crohn's Disease

      Active, not recruiting
      • Crohn Disease
      • Guangzhou, China
      • +4 more
      Jan 31, 2023

      Early Bowel Resection for Terminal Ileal Crohn's Disease

      Recruiting
      • Crohn Disease
        • Sheffield, United Kingdom
          Sheffield Teaching Hospitals NHS Foundation Trust
        Oct 30, 2023

        Crohn Disease Trial (Azathioprine + infliximab, Intestinal resection)

        Not yet recruiting
        • Crohn Disease
        • Azathioprine + infliximab
        • Intestinal resection
        • (no location specified)
        Oct 14, 2022

        IBD, Crohn Disease, Ulcerative Colitis Trial in Eindhoven, Heerlen, Veldhoven (MedicijnWijs)

        Recruiting
        • Inflammatory Bowel Diseases
        • +2 more
        • MedicijnWijs
        • Eindhoven, Noord-Brabant, Netherlands
        • +2 more
        Apr 4, 2022

        Crohn's Disease Trial in France (Phase1 : CDED/Modulen™IBD® + Maintenance therapy, Phase2 and 3 :)

        Not yet recruiting
        • Crohn's Disease
        • Phase1 : CDED/Modulen™IBD® + Maintenance therapy
        • Phase2 and 3 :
        • Bron, France
        • +3 more
        Feb 9, 2022